Special Research Seminar - Dung Le, M.D.

About this event

Special Research Seminar - Dung Thi Le, M.D.

Sponsored by Simmons Comprehensive Cancer Center

"Translating Preclinical Promise in Pancreatic Cancer: A Clinical Investigator's Perspective"

Dung Thi Le, M.D.

Professor of GI Oncology

Director, GI Oncology Clinical Trials

John Hopkins University School of Medicine

Thursday, November 19th | 12:00pm

NB5.124 Seminar Room ( In Person Preferred)

ZOOM | Meeting ID: 989 6258 2910 | Passcode: 211548

About Dr. Dung Le:

Dung Le, M.D. is a professor of oncology at the Johns Hopkins University School of Medicine and member of the Johns Hopkins Kimmel Cancer Center. Her research interests include novel approaches to patients with gastrointestinal malignancies. She has served as the principal investigator (PI) on many clinical trials focused on testing immunotherapy in patients with gastrointestinal malignancies and she has also served as the national PI on several studies including: anti-programmed death-1 (PD-1) in tumors with mismatch repair deficiency; a clinical trial in advanced pancreatic cancer patients evaluating the safety, tolerability and immune response to CRS-207, a listeria vaccine platform which has been modified to express the tumor antigen mesothelin; a multi-center, phase 2 study testing CRS-207 as a boost to allogenic pancreatic tumor cells transfected with GM-CSF gene (GVAX) for treatment of advanced pancreatic adenocarcinoma (PDA); a trial testing GVAX/ipilimumab in the maintenance setting for metastatic pancreatic cancer; and GVAX/CRS-207 +/- nivolumab in metastatic pancreatic cancer.

These studies incorporate extensive laboratory correlates and have involved collaborations with clinicians and bench scientists with expertise in the fields of immunotherapy and cancer genomics.

Learn more about the PI: https://profiles.hopkinsmedicine.org/provider/dung-le/2709398